Diplomat Pharmacy Inc (DPLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,485 | 84,251 | 7,953 | 27,600 | 17,957 |
| Receivables | 326,602 | 332,091 | 275,568 | 254,682 | 155,273 |
| Inventories | 210,573 | 206,603 | 215,351 | 165,950 | 110,683 |
| Income taxes - deferred | N/A | N/A | N/A | 5,311 | 1,813 |
| TOTAL | $556,256 | $634,070 | $505,107 | $460,970 | $291,086 |
| Non-Current Assets | |||||
| PPE Net | 34,525 | 38,990 | 20,372 | 16,538 | 13,150 |
| Investments And Advances | 0 | 0 | 0 | 4,959 | 3,500 |
| Intangibles | 850,402 | 1,224,635 | 516,478 | 480,962 | 68,121 |
| Other Non-Current Assets | 35,176 | 42,728 | 57,297 | 38,150 | 14,229 |
| TOTAL | $920,103 | $1,306,353 | $594,147 | $540,609 | $99,000 |
| Total Assets | $1,476,359 | $1,940,423 | $1,099,254 | $1,001,579 | $390,086 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 187,800 | 199,750 | 46,755 | 6,000 | 0 |
| Accounts payable and accrued liabilities | 331,348 | 413,463 | 320,684 | 296,587 | 202,495 |
| Accrued Expenses | 18,423 | 17,684 | 5,674 | 58,228 | 12,933 |
| Other current liabilities | 21,014 | 20,560 | N/A | N/A | N/A |
| TOTAL | $558,585 | $651,457 | $385,346 | $371,902 | $215,428 |
| Non-Current Liabilities | |||||
| Long Term Debt | 438,369 | 521,098 | 100,184 | 106,706 | 0 |
| Other Non-Current Liabilities | 6,365 | 4,322 | 3,253 | 1,004 | 5,638 |
| TOTAL | $452,690 | $539,465 | $100,184 | $114,131 | $5,931 |
| Total Liabilities | $1,011,275 | $1,190,922 | $485,530 | $486,033 | $221,359 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 74,490 | 74,069 | 66,988 | 64,549 | 51,457 |
| Common Shares | 629,411 | 619,235 | 503,828 | 451,620 | 148,901 |
| Retained earnings | -210,579 | 91,816 | 76,306 | 31,130 | 5,354 |
| Other shareholders' equity | -4,292 | 0 | 322 | 3,575 | 4,579 |
| TOTAL | $465,084 | $749,501 | $613,724 | $515,546 | $168,727 |
| Total Liabilities And Equity | $1,476,359 | $1,940,423 | $1,099,254 | $1,001,579 | $390,086 |